4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-027985
Chief Financial Officer sold 319 shares at $13.11 ($4,182)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Trigilio Jeffrey Chief Financial Officer | 2023-06-12 | Sale | −319 | $13.11 | $4,182 | 86,222 | D |
| Open-market sales · 319 sh · avg $13.11 · $4,182 | |||||||
Loading xslF345X04/ownership.xml…